Periodic Reporting for period 1 - geneTIGA (Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology)

The prevalence of chronic diseases stemming from dysregulated immune responses is on the rise, affecting over 10% of the population and imposing a substantial burden on both individuals and society at large. Patients grappling with these conditions endure persistent health...